Finance & Economics

Hermès’ stunning success raises the question: What’s ev...

Hermès' executive chairman believes "it’s not the success of Hermès, but the wor...

Stock-Split Watch: Is Meta Platforms Next?

Meta Platforms (NASDAQ: META) isn't a cheap stock anymore, at least on a dollars...

Here's How Many Shares of Enterprise Products Partners ...

Dividend growth has contributed massively to this 6.5%-yielding stock's returns ...

Should You Buy Nvidia Stock Before Feb. 26?

Nvidia (NASDAQ: NVDA) is scheduled to report an update that could have enormous ...

Nestle and Sources Alma face investigations over French...

New investigations have emerged just a few months after Nestle Waters admitted t...

Alibaba shares jump after reports that founder Jack Ma ...

Xi's crackdown brought the cancellation of Alibaba affiliate Ant Group's blockbu...

Jeff Bezos-backed Blue Origin to cut 10% of its workforce

Blue Origin has drawn unfavorable comparisons to Elon Musk’s SpaceX, which leapf...

Accenture CEO Julie Sweet’s cancer diagnosis

Also: Jamie Dimon hits back at RTO criticism, Ray Dalio sends deficit warnings.

How CEOs should handle a cancer diagnosis

Also: Jamie Dimon hits back at RTO criticism, Ray Dalio sends deficit warnings.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.